GLL Health Sciences Fund Ltd
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Cayman Islands
- Sector
- Services
- Headquarters
- Po Box 10324 Grand Cayman, E9
- Street
- C/ofive Continents Partners LTD
- Zip
- KY1-1003
Offering
- Total offering
- —
- Amount sold
- $8.3M
- First sale
- Jan 1, 2017
- Min investment
- $250k
- Securities
- Pooled investment fund
- Federal exemption
- Rule 506(b)
- Investors so far
- 11
How this filing compares
Other E9 filings this week: Alfreton Leopard Fund Ltd, Alpha Wave CI II, LP, Bayberry Offshore Ltd, Contrarian Emerging Markets Offshore Fund, Ltd., Dilation Offshore Long, Ltd.
Leadership
GLL Investors LLC — Promoter
Also named on: GLL Health Sciences Fund LLC
William Stephen Gilboy — Executive Officer (also: Promoter)
Also named on: GLL Health Sciences Fund LLC
Jason Gilboy — Executive Officer (also: Director, Promoter)
Also named on: GLL Health Sciences Fund LLC
Michael Newlander — Executive Officer (also: Promoter)
Also named on: GLL Health Sciences Fund LLC
Wayne Ross — Director
Also named on: GLL INVESTORS, LTD
Filing details
GLL Health Sciences Fund Ltd filed a Form D with the SEC on March 31, 2026.